Next Article in Journal
Foot Bionics Research Based on Reindeer Hoof Attachment Mechanism and Macro/Microstructures
Next Article in Special Issue
Towards the First Generation of Biomimetic Fixation for Resurfacing Arthroplasty Endoprostheses
Previous Article in Journal
Robust Superhydrophobicity through Surface Defects from Laser Powder Bed Fusion Additive Manufacturing
Previous Article in Special Issue
Designing Biomimetic Conductive Gelatin-Chitosan–Carbon Black Nanocomposite Hydrogels for Tissue Engineering
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

TCP Doped with Metal Ions Reinforced with Tetragonal and Cubic Zirconia

by
Vanessa M. Ferro
1,2,
Beatriz C. Silva
1,
Duarte F. Macedo
1,
Natanael F. Fernandes
2 and
Abílio P. Silva
1,*
1
C-MAST—Centre for Mechanical and Aerospace Science and Technologies, Universidade da Beira Interior, Rua Marquês d’Ávila e Bolama, 6201-001 Covilhã, Portugal
2
CICS-UBI—Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal
*
Author to whom correspondence should be addressed.
Biomimetics 2023, 8(8), 599; https://doi.org/10.3390/biomimetics8080599
Submission received: 17 October 2023 / Revised: 19 November 2023 / Accepted: 7 December 2023 / Published: 12 December 2023
(This article belongs to the Special Issue Biomimetic Scaffolds for Hard Tissue Surgery)

Abstract

:
Ceramic biocomposites based on bioactive tricalcium phosphate doped with metal ions are a strategy for obtaining good biomimetics for human bone composition. Manufacturing with PMMA porogen also induces bone-like porosity morphology. The poor strength of tricalcium phosphate can be overcomed by designing ceramic composites reinforced with tetragonal and cubic zirconia. In this work, five different bioceramic composites were manufactured without and with induced porosity and their physical, mechanical, microstructural, and biological properties were studied. With the addition of tetragonal and cubic zirconia, an improvement in strength of 22% and 55%, respectively, was obtained, corresponding to up to 20.7 MPa. PMMA was suitable for adding porosity, up to 30%, with interconnectivity while an excellent hOB cellular viability was achieved for all biocomposites.

1. Introduction

The average life expectancy has increased, causing the aging of the world population. With this, health complications related to joints and bone tissue, such as osteoporosis and osteoarthritis, can arise [1,2]. Therefore, finding alternatives that provide quality of life to the patient is essential. Inert bioceramics (e.g., zirconia, ZrO2), do not form biochemical bonds with surrounding tissues, i.e., do not react with the body [3]. Physical, chemical, and mechanical properties such as high compressive strength, wear and corrosion resistance, hardness, elastic modulus similar to that of steel, high fracture toughness, and stability in a physiological environment, make ZrO2 a material of the highest interest for the manufacture of orthopedic and dental prostheses [2,4].
At room temperature and in pure form, ZrO2 has a stable monoclinic crystalline structure (m-ZrO2) up to 1170 °C. With increasing temperature, it becomes metastable: tetragonal (t-ZrO2) stable up to 2370 °C and above this temperature, cubic (c-ZrO2) [4,5,6]. The m-ZrO2 is not suitable for high temperature applications due to the volume expansion associated with the transformation of t-ZrO2 to m-ZrO2 [7,8], known as martensitic transformation [5,9]. In this transformation there is an increase in volume of approximately 4.5% during cooling [6,8] which is detrimental to the mechanical behavior of ZrO2 because the stress induced during this transformation leads to the formation of cracks [5]. In this sense, it can be concluded that the oral environment is a strongly predisposing factor for uncontrolled martensitic transformation [6].
Stabilizers such as yttrium oxide (Y2O3) can be added to ZrO2 to inhibit the transformation of the t-phase to m-phase. Briefly, this addition results in the part of the Zr+4 atoms being replaced by Y+3 atoms, stabilizing the polymorphic modifications of ZrO2 when subjected to the sintering process. This avoids the volume variations caused by phase transformations [6,10] that form yttrium-stabilized zirconia (YSZ), where 3YSZ is mostly tetragonal and 8YSZ is mostly the cubic crystalline phase [11]. However, several studies describe that the use of Y2O3 has disadvantages mainly in its degradation at low temperature; this phenomenon is known as “Aging Phenomenon” while its use is limited by unpredictable behavior in the body [1,6,9,12].
On the other hand, active bioceramics can establish connections with the surrounding tissue and suffer progressive degradation as the new tissues form [13]. TCP can be used in cement and bone implants for its bioactivity, osteoinduction, and bioresorbability [14,15]. By its reabsorbable nature, part of the material dissolves, providing raw material for the growth and maintenance of the new tissue, facilitating osteoconduction [13,16]. Chemically, it is Ca3(PO4)2 and characterized by a Ca/P ratio 1.5 [17]. As a function of the temperature at which it is sintering, it can present three polymorphic forms: β-TCP (~<1150 °C), α-TCP (~1150–1460 °C), and α’-TCP (~>1460 °C) [18,19].
Metal ions such as magnesium (Mg2+), manganese (Mn2+), zinc (Zn2+), iron (Fe3+), and strontium (Sr2+), among others, can be added to form biomimetic bone composition and also improve several properties of these bioceramics [14,20]. Considering the cations in the human body, magnesium is the fourth in abundance and the second intracellular cation in tissues [21,22]. The human body contains about 30 g of magnesium, 50% stored in bones [23]. Magnesium plays a vital role in many enzymatic reactions, among which are the transmission of nerve impulses and the synthesis of fatty acids and proteins. Also, Mg2+ has an elemental role in biology because ATP needs to be bound to a magnesium ion to be biologically active as well as in the formation of the transition state where ATP is synthesized from ADP and inorganic phosphate. Mg2+ ions can replace Ca2+ ions by increasing the transformation temperature of β to α, stabilizing β-TCP, increasing mechanical strength, and improving osteoblast function and biocompatibility. Moreover, Mn2+ ions improve mechanical properties and corrosion resistance, while Zn2+ improves osteoblast function, corrosion resistance, and has antibacterial action. Other cations, such as Fe3+ preserve the structural stability of bioceramics and increase osseointegration, while Sr2+ inhibits bone resorption and stimulates the proliferation of osteoblasts and bone formation [14,20,24,25,26,27,28,29].
However, besides the essential effect of metal ions for human life, higher doses can be toxic [23]. For instance, levels of Mg2+ above 1.1 mM are generally considered hypermagnesemic. This effect promotes patients clinically to suffer from nausea, vomiting, lethargy, headaches, and/or flushing. When Mg2+ levels rise above 3.0 mM, it can cause serious heart defects, characterized by brachycardia, hypotension, and in extreme hypermagnesemia can result in coma, asystole, and death from cardiac arrest [22].
Manganese (Mn2+) ions accumulate in the bones, liver, pancreas and mainly in the brain. Pathologies, as polycythemia, dystonia, hepatic cirrhosis, have been related to excess of manganese. In particular, symptoms as in Parkinsonism have been reported to overexposure of manganese. The molecular mechanisms involved include oxidative stress, protein misfolding, apoptosis, mitochondrial dysfunctions, and interference in the homeostasis of other metal essential ions. The Mn2+ amount should not exceed 5 mg/m3, even for short periods; however, its toxicity depends on its chemical form: -Mn2+, the common form, is not dangerous but MnO4 is very toxic [23].
High concentration of Zinc (Zn2+) can be found in vesicles in the brain, in bones, and in muscles. It is reported that the recommended dose is around 15 mg/day [23]. Poisoning with zinc phosphide, a rodenticide, causes cardiovascular, respiratory, renal, and hepatobiliary failure, among other complications [30].
In vitro studies have shown that high doses of iron could lead to osteoblast apoptosis via caspase 3. Iron overload also decreases the formation of mineralization nodes and inhibits growth of hydroxyapatite crystals, altering their crystallinity [30]. The toxicity generated by the excess of iron can cause cirrhosis, liver carcinoma, heart failure, diabetes mellitus, and osteoporosis. Therefore, in the presence of molecular oxygen, loosely bound iron is able to undergo a redox cycle (Fe3+/Fe2+) generating poisonous oxygen-derived free radicals [23].
For successful applications, bone structures must mimic the porosity of native bone and allow it to grow through the interconnectivity of the structure [31]. Polymethylmethacrylate (PMMA) has been considered for its particular characteristics, such as mechanical strength, moldability to fill complex defects, low cost, having approval by the FDA and with clean and easy thermal elimination at high temperatures [32,33,34].
The aim of this work was to produce dense ceramic biocomposites and PMMA induced porous ceramic biocomposites, both compositions based in TCP, doped with metal ions of magnesium (Mg2+), manganese (Mn2+), zinc (Zn2+), and iron (Fe3+). The two types of manufactured samples were reinforced with 10 wt% and 20 wt% of tetragonal zirconia (3YSZ) and cubic zirconia (8YSZ). A detailed evaluation of their physical, mechanical, microstructural, and biological properties was performed.

2. Materials and Methods

2.1. Materials and Manufacture Methods

Following the procedure described in the literature [14], TCP was doped with 10 mol% of Mg2+ and 5 mol% of a mixture of Zn2+, Mn2+, and Fe3+, totaling 15 mol% of metal ions. Being similar to the maximum amount of Ca2+ ions that can be replaced in the TCP structure, substituted TCP (sTCP) was obtained in this way [24]. For this purpose, calcium carbonate (CaCO3, PanReac AppliChem, Barcelona, Spain), ammonium phosphate dibasic ((NH4)3HPO4 Acros organics, Geel, Belgium, 98+%, CAS: 423375000), magnesium oxide (MgO, Alfa Aesar, Ward Hill, MA, USA, 96% min, CAS: 1309-48-4), manganese (II) oxide (MnO, 99%, Alfa Aesar, Ward Hill, MA, USA, CAS 011870-36), iron (III) oxide (Fe2O3, 99.9%, Alfa Aesar, Ward Hill, MA, USA, CAS: 1309-37-1), and zinc oxide (ZnO, 99.0%, PanReac AppliChem, Barcelona, Spain, CAS: 1314-13-2) were used. Also, ZrO2 stabilized with 3 mol% of yttrium (3YSZ, TZ-3Y, t-ZrO2, Tosoh, Tokyo, Japan, Lot: Z308782P), ZrO2 stabilized with 8 mol% of yttrium (8YSZ, TZ-8Y, c-ZrO2, Tosoh, Tokyo, Japan, Lot: Z807724P), and PMMA microspheres (Acros Organics, Geel, Belgium, CAS: 9011-14-7), with average size of 100 µm, were also added to induce porosity in some samples. Calcium carbonate, ammonium phosphate dibasic, 10 mol% of Mg, and 1.67 mol% of Zn2+, 1.67 mol% of Mn2+ and 1.67 mol% of Fe3+ in total amount of 50 g was mixed with 100 g of isopropyl alcohol (Labchem, Laborspirit, Santo Antão do Tojal, Portugal) in a high energy ball mill (Fritsch, Pulverisette 6, Idar-Oberstein, Germany) at 500 rpm for 150 min, divided into cycles of 30 min. To promote this mixing and simultaneous milling process, 50 g of YSZ spheres (Fritsch, Idar-Oberstein, Germany) were used. The mixture was dried in a stove (Carbolite, NR200-F, Derbyshire, UK) at 60 °C for 48 h. After this process, the mixture was sieved (Retsch, AS200, Düsseldorf, Germany) up to 63 μm to remove the YSZ spheres and some agglomerates. The laser diffraction method (Beckman Coulter, LS200, Brea, CA, USA) was used to analyzed the particle size distribution of the powders after milling. Then, the powder was placed in crucibles and calcined in an electric furnace (Termolab, MLR, Águeda, Portugal) in air for 10 h at a temperature of 1000 °C. After calcination of the sTCP reference material, the other four ceramic composites with 3YSZ and 8YSZ were mixed according to the compositions and nomenclatures summarized in Table 1.
To each of the compositions with YSZ, 3YSZ and 8YSZ were added according to the corresponding mass fraction. Then, 15 g of the doped or substituted TCP (sTCP) was added according to the mass fraction, and 15 g of YSZ balls and 30 g of isopropyl alcohol were mixed in a high energy ball mill [35]. The milling, drying, and sieving processes occurred under the previous conditions. The particle size distribution (PSD) of the powders of the reference material (sTCP, which give rise to the material designated 10T) and the other compositions with the mixture between 80% of sTCP, 20% of cubic zirconia (8T2cZ), and 20% of tetragonal zirconia (8T2tZ) are shown in Figure 1.
The PSD of 10T powders is bimodal: with a major peak at 10 µm and another minor peak at 1 µm. Both compositions have zirconia (8T2cZ and 8T2tZ) present, instead of one, with two small minor peaks of 0.5 and 1.8 microns, respectively.
To induce porosity, PMMA spheres were added to each of the five compositions in the mass fraction 60:40 (each of the five compositions: PMMA, respectively). In order to obtain a homogeneous mixture, the mixture was placed in the Fritsch mill for 20 s at 500 rpm.
Cylindric pellets of bioceramic composites with mass of ~0.65 g, ~13 mm diameter and 3 mm thickness were made using a universal electromechanical testing machine (Shimadzu, AGS-X, Kyoto, Japan) with a 13 mm diameter stainless steel matrix in which uniaxial pressure of 50 MPa was applied for 10 s. Then, the samples were sintered in air at a temperature of 1300 °C for 120 min with a heating rate of 5 °C/min.

2.2. Microstructural and Mechanical Characterization

To confirm if the doping reaction occurred, the XRD test was performed in the dense biocomposites 10T, 8T2tZ, and 8T2cZ, since 8T2tZ and 8T2cZ have the highest concentration of each ZrO2 studied and 10T the same concentration of each ion without the addition of 3YSZ and 8YSZ. An X-ray diffractometer (DMAX III/C, Rigaku, Tokyo, Japan) with the Bragg-Brentano (θ/2θ) horizontal geometry was used. The X-ray tube of copper (wavelength of 1.5405 Å) operated at 40 kV at 30 mA using CuKα radiation. The intensity of diffracted radiation as function of the 2θ diffraction angle was obtained between 5° and 90°. The diffractograms obtained were compared with the theoretical cards available in the ICDD database of the MDI/JADE, version 6 analysis software. The contents of each crystalline phase of the compositions in %vol were quantified through Rietveld refinements using the FullProf software, version May2021 [36]. Scanning electron microscopy (SEM) (Hitachi S-2700, Tokyo, Japan), was performed for microstructure imaging by applying the SE mode at an accelerating voltage of 20 kV. Chemical analysis was performed using SEM with energy dispersive X-ray probe (EDX, Brucker Quantax 400, Elk Grove Village, IL, USA). This analysis was carried out using the average of three different areas, where the gold peaks were not considered and all other peaks corresponding to Ca, P, and O and also the metals such as Zr, Mg, Mn, Fe, and Zn were quantified.
Fourier transform infrared spectroscopy (FTIR) was performed using a NicoletTM iS 10 FTIR spectrometer (Thermo Scientific Inc., Waltham, MA, USA). Infrared spectra were recorded in the range of 525–4000 cm−1 at ambient temperature and with a resolution of 4 cm−1 (32 scans).
Apparent porosity and bulk density were measured according to ASTM C20-00 [37]. In this procedure three different weights, in grams, were calculated: dry sample weight (D), saturated weight (W), after boiling for 2 h and resting 12 h entirely covered with water, and suspended immersed in water weight (S). Considering the density of the water equal to 1 g/cm3, the apparent porosity, P, in %, expressing the relationship of the volume of the open pores in the specimen to its exterior volume, is calculated using Equation (1):
P = W D W S × 100
The bulk density, BD, in g/cm3, is the quotient of its dry weight divided by the exterior volume, including pores, and is calculated by Equation (2):
B D = D W S
The diametral compression test was conducted with a universal electromechanical testing machine (Shimadzu, AGS-X, Japan) with a load cell of 10,000 N [38] and a displacement rate of 0.5 mm/min [39]. The tensile strength, σx, was determined by Equation (3) where F corresponds to the maximum force applied, d, the diameter, and e, the thickness of the cylindric sample:
σ x = 2 × F π × d × e
In Figure 2, the illustrations of dense and porous ceramic samples are observed after the fracture occurs during the diametral compression test.

2.3. Biological Characterization

The resazurin assay [40] was used to evaluate the cytocompatibility of bioceramic composites in human osteoblasts (hOB). Thus, a cell line of hOB (Cell Applications, Inc., San Diego, CA, USA), t-flasks of 75 cm3 cell culture (Orange Scientific, Braine-l’Alleud, Belgium), Dulbecco’s Modified Eagle Medium/Nutrient F-12 (DMEM-F12, Sigma-Aldrich, Sintra, Portugal), sodium bicarbonate (NaHCO3, Labchem, Laborspirit, Santo Antão do Tojal, Portugal, CAS: 144-55-8), double deionized water (ultrapure water, obtained using an ultrapure water purification system Milli-Q Advantage A10, filtered at 0.22 μm and 18.2 MΩ cm at 25 °C), bovine fetal serum (FBS, Biochrom AG, Berlin, Germany, CAS: 9014-81-7), trypsin (Sigma-Aldrich, Sintra, Portugal, CAS: 9002-07-7), resazurin (Sigma-Aldrich, Sintra, Portugal, CAS: 62758-13-8), spectrofluorimeter (SpectraMax Gemini EM Molecular Devices, San José, CA, USA), scanning electron microscope (Hitachi, S-3400 N, Tokyo, Japan) and a turbomolecular pumped coater (Quorum Technologies, Q150R ES, Lewes, UK) were used.
Discs similar to those used in the mechanical characterization (Figure 2) of ~13 mm in diameter and 3 mm in thickness were broken into six identical parts, and before starting the biological tests, were sterilized by ultraviolet irradiation (UV) for 1 h [1]. The cells were seeded at a density of 15,000, 10,000, and 2500 cells/well in three 48-well plates for 24 h at 37 °C. Then, the medium was removed, and the cells were incubated with 10% of material in relation to the well area [41] and 300 μL of DMEM-F12 in all wells. After 1, 3, and 7 days of incubation, the medium and the material were removed and the hOB were incubated with 220 μL resazurin 10% (v/v) [40,42]. Cell viability was determined by measuring resorufin fluorescence at λex = 545 nm and λem = 590 nm [40,42]. The plate corresponding to day 1 of incubation with material contained a density of 15,000 cells/well, day 3, 10,000 cells/well, and day 7 plate, 2500 cells/well. Negative control (K) cells were incubated only with culture medium and positive control (K+) cells were incubated with bleach.
The cellular attachment to porous biocomposites was assessed by SEM analysis in BSE 3D mode (Backscattered electrons) with an acceleration voltage of 20 kV. The cells were fixed with 500 μL of glutaraldehyde at 2.5% (v/v) for 1 h. After, the samples were dehydrated with increasing ethanol concentrations (50, 70, and 99%) for 5 min each, frozen at −80 °C for 1 h and freeze-dried for 3 h. Then, the samples were coated with gold using a turbomolecular pumped coater.

3. Results and Discussion

3.1. Microstructural Properties

Representative SEM micrographs of the fracture surfaces of the sintered ceramic composites are shown in Figure 3. In all cases there are mixed fracture surfaces, that is, transgranular (examples illustrated by letter “T” in Figure 3) and intergranular fractures (examples illustrated by letter “I” in Figure 3). Regarding porosity, it is evident that an interconnected porosity network exists even in dense biocomposites. In addition to perfectly spherical pores, that is, pores caused by PMMA spheres, more elongated pores are also observed.
The macropores caused by the PMMA spheres, visible in the image at 200× magnification, present an average size of 100 µm, between 120–150 µm and between 110–140 µm for the 10T, 8T2tZ, and 8T2cZ biocomposites, respectively. In this way, bone growth and cell colonization have good conditions to occur.
XRD assays were performed to confirm the presence of ZrO2 crystalline phases in the dense biocomposites 8T2tZ and 8T2cZ. Figure 4 shows the X-ray diffraction spectra of the analyzed biocomposites. In the 10T biocomposites, in addition to other small, identified peaks, four main peaks of higher intensity were identified for 2θ = 27°, 32°, 34°, and 53° that correspond to β-TCP and are coincident with their theoretical card. The predominant structure is β-TCP (~78%vol according to Table 2). Also, in 10T samples, HA is the second most present phase, and α-TCP, with a very low value, can be neglected. The existence of α-TCP was not expected, because of the doping of TCP with 10% MgO. According to the literature [24], with the addition of Mg2+ to TCP, the transformation temperature of β-TCP to α-TCP is expected to increase. This is also promoted by the relative high temperature of sintering. In biocomposites 8T2tZ and 8T2cZ, four main peaks were identified for 2θ = 30.2°, 31.1°, 50.4°, and 59.7° corresponding to t-ZrO2, β-TCP, t-ZrO2, and also t-ZrO2, respectively, for 8T2tZ; in 8T2cZ main peaks for 2θ = 30°, 31.1°, 50.1° and 59.7° were identified, corresponding to c-ZrO2, β-TCP, c-ZrO2, and also c-ZrO2, respectively. For both cases, the peaks coincide with the respective theoretical cards.
The main phases of the biocomposites analyzed were quantified by Rietveld refinement, as shown on Table 2. According to Table 2, the predominant phase is β-TCP, presenting values of 77.60, 71.09, and 77.50%vol for biocomposites 10T, 8T2tZ, and 8T2cZ, respectively. HA was only detected in 8T2tZ and 10T, with values of 3.05 and 21.69%vol, respectively. In biocomposites with 8YSZ, mostly this phase corresponds to ZrO2, c-ZrO2, whose value is 21.02%vol, and a small percentage of t-ZrO2, 1.48%vol, which indicates that during the manufacturing process the c-ZrO2 was converted into t-ZrO2, probably due to high temperatures. In the biocomposites with 3YSZ, only t-ZrO2, was quantified, 25.86%vol.
No metal oxides were detected, including MgO, which indicates that during the calcination process, the Ca2+ ions were replaced by the metal ions of Mg2+, Mn2+, Zn2+, and Fe3+ into sites of the crystalline structure of β-TCP.
In order to understand the presence of several peaks corresponding to HA, the XRD was carried out for sTCP after the calcination process and compared with the XRD after the sintering process (Figure S1). The main peaks correspond, in both spectra, to the TCP beta phase. The presence of TCP alpha crystalline phase peaks is unclear. In the calcined sTCP sample, the peaks for 2θ = 29°, 31.8°, 32.2°, 32.9°, 34.0°, 39.2°, 46.7°, 49.5°, and 63.0° correspond to the hydroxyapatite phase. In the sintered phase at 1300 °C, the number of HA peaks decreases, essentially leaving the relevant peaks at 31.8°, 32.2°, and 32.9°.
The formation of hydroxyapatite in this case most likely occurs through what in the literature is called mechanochemical synthesis [43,44]. These mechanochemical reactions resulted in the formation of a defective phase of calcium-deficient HA, which, when calcined at up to 720 °C, leads to the formation of HA and β-TCP [43]. The principle of this dynamic synthesis during grinding is related to the energy during grinding (the impact that the mill balls have on the powdered grains). In other words, a reaction and an interdiffusion mechanism are promoted between different grains or with an intimate chemical reaction of the molecules between them [44]. In this sense, similar to the present work, after 5 h of mechanical activation, Yeong et al. [43] obtained a 2θ of 31.8° as the most prominent peak, corresponding to the crystalline plane of HA (211).
In fact, the growth of the HA phase, which is directly related to the improvement of biocompatibility and osteoinduction, is important in bone reconstruction [1,18,45].
From the elementary chemical analysis (EDX), Table 3, the presence of the elements Ca, P, Zr, and the remaining added metal ions were verified.
The elements Ca and P come from the chemical formula of TCP, (Ca3(PO4)2), and the Zr from the doping with the two types (tetragonal and cubic) of ZrO2 used in the composition of the ceramic biocomposites. The Ca/P ratio, in wt%, of 2.68, 3.53, and 3.37, and in mol% of the 2.07, 2.73, and 2.60 for the ceramic biocomposites 10T, 8T2tZ, and 8T2cZ, respectively is slightly high when compared to the works reported in the literature, namely, Wu et al. [46], which refers to bone minerals with Ca/P ratio between 1.37 and 1.87 mol%. With the addition of the 3YSZ and 8YSZ, this Ca/P ratio, tends to increase, with its highest value being in ceramic biocomposites with 20% of 3YSZ.
Figure 5 shows the characteristic FTIR spectra of the biocomposites.
From the FTIR analysis, the characteristic covalent bonds of the different ionic groups are observed. The ceramic compound TCP is formed by Ca2+ and PO3− ions. The peak at 943.19 cm−1 and 972.12 cm−1 is related to the presence of pure β-TCP. Thus, the bands between the range 900–1200 cm−1 represent the stretching mode of the PO4−3 group [47,48]. The results show the characteristic peaks of the covalent bonds present in PO4−3. Hydroxyapatite (HA) has the OH ion. The characteristic peaks at 630 cm−1 and 3571 cm−1 were attributed to the stretching mode of the hydroxyl group (OH) [47]; however, these peaks were not clearly detected or were too small compared to others. The band at 465–627 cm−1 and the band at 900–1000 cm−1 were expected due to Zr-O, which indicates the formation of cubic ZrO2 and tetragonal ZrO2 crystalline phases, respectively [49,50]. In this sense, it is believed that the peaks with the greater width of the two samples with zirconia (~600 cm−1), in comparison with the sharp peaks of the 10T composition, and the more pronounced drop (~820 cm−1), are due to the presence of Zr-O bonds, thus being almost undetectable due to their low content and the presence of high PO43− peaks in this region.

3.2. Mechanical Properties

The apparent porosity of the 10T biocomposite was 12.9%. The porosity increased to 24.6% and 21.9% for the dense biocomposites reinforced with 3YSZ, i.e., 9T1tZ and 8T2tZ, respectively. The similar samples manufactured with PMMA show higher porosity, namely, 26.2%, 29.0%, and 29.3% for 10T, 9T1tZ, and 8T2tZ, respectively. The dense biocomposites of 9T1cZ and 8T2cZ showed lower apparent porosity with reinforcement of 10 wt% of 8YSZ (14.9%) and similar porosity for 20 wt% (20.7%). The samples manufactured with PMMA present similar porosity of 28.9% and 27.6%, for 10 wt% and 20 wt%, respectively. In both manufacturing conditions, the addition of 3YSZ or 8YSZ increased the apparent porosity in relation to the standard, 10T, see Figure 2, Figure 3 and Figure S2.
The bulk density of the sTCP doped with metal ions (reference material, 10T) presented a value of 2.80 g/cm3. The density increased for 3.19 g/cm3 and 3.36 g/cm3 and for 3.18 g/cm3 and 3.35 g/cm3 for the dense biocomposites reinforced with 3YSZ and 8YSZ, respectively. The samples manufactured with PMMA, with 10 wt% and 20 wt% of 3YSZ, present a density of 2.30 g/cm3 and 2.62 g/cm3, respectively. While the porous samples reinforced with 10 wt% and 20 wt% of 8YSZ, show 2.73 g/cm3 and 2.60 g/cm3, respectively. The addition of 3YSZ and 8YSZ in dense biocomposites increased the density related to initial doped sTCP. However, in the samples manufactured with PMMA the density decreased or presented similar values (Figure 3 and Figure S3).
These results are in agreement with the literature [1,18,31,45]. There, it was proven that, with the addition of 10 and 20% ZrO2, the apparent porosity increased while the bulk density decreased, and this is what happened with the porous biocomposites analyzed in this work. With the addition of the 3YSZ and 8YSZ, porosity and bulk density increased, which can be explained by the effect of the sintering temperature (1300 °C). Considering the particle size distribution of the mixture up to 10 µm, with both zirconias up to 2 µm, the sintering conditions by pressure-less, unassisted sintering where, in general, densification is accompanied by (an undesirable) grain coarsening, the success of avoiding the grain growth is related to the control of the competition between densification and grain growth. That is extremely difficult because the driving forces for both are proportional to the reciprocal grain size and hence comparable in magnitude [51]. Thus, for the composition, particle size, and single step sintering in air the temperature used is not sufficient to promote the grain boundary atomic migration of zirconia. In these conditions, only the approximation of zirconia particles promotes the formation of zirconia agglomerates and partial grain growing with poor densification and superior porosity [52]. Nonetheless, the addition of ions like Mg2+ promotes the densification of materials [18,45]. Another explanation for the apparent porosity results in the use of the biocomposites manufactured with PMMA (40 wt%). Lee et al. [31] showed that, with different percentages of PMMA, starting with 40%, the porosity tends to increase gradually, and even with 40% the value is already quite considerable.
The diametrical compression tests revealed that the dense biocomposites with 3YSZ and 8YSZ presented mechanical strength values between 12.85 and 16.40 MPa and between 13.36 and 20.74 MPa, respectively (Table 4).
These results revealed that, in comparison with sTCP doped (13.4 MPa), the dense biocomposites with 20 wt% of 3YSZ and 8YSZ are higher. The samples 8T2cZ, are those that have higher mechanical strength, with a value of 20.7 MPa (55% higher than reference doped sTCP). As expected in induced porous biocomposites, the mechanical strength values were greatly decreased. From the initial 1.28 MPa (TCP doped) the addition of the 20 wt% of ZrO2 decreases to 0.1 and 0.14 MPa for 3YSZ and 8YSZ, respectively (Figure S4).
The addition of ZrO2 to the ions doped with sTCP creates a ceramic microstructure in which the sTCP base matrix is reinforced with micro- and nanoparticles of zirconia (3YSZ and 8YSZ) which is due to its superior mechanical resistance (strength, toughness, and hardness). Furthermore, it is evident that the superior mechanical properties of the cubic phase (8YSZ) contribute more effectively to the increase in resistance than the tetragonal phase (3YSZ) [53].
Similar to previous studies, biocomposites with reinforcement of ZrO2 have higher mechanical strength than “pure” biocomposites, i.e., biocomposites without the presence of ZrO2 [1,54,55]. In this study the most resistant biocomposites have 20% of 3YSZ or 8YSZ. On the other hand, these results can also be explained by the addition of Mg2+, that replaces the Ca2+ ions in its sites (doping effect), which have already been shown to increase the mechanical strength of the biocomposites [45]. Regarding biocomposites manufactured with PMMA, low mechanical strength was already reported by Lee et al. [31].

3.3. Biological Properties

The biocompatibility of dense ceramic biocomposites, both with and without porosity induced by PMMA reinforcement with 3YSZ and 8YSZ, was evaluated using a resazurin assay, with the corresponding results displayed in Figure 6. hOB were chosen as the cell model due to their pivotal role in bone matrix production and remodeling [56], a crucial aspect of the osseointegration process. Notably, the data obtained from the resazurin assay, as shown in Figure 6A,B, demonstrated that even after 7 days of incubation, the hOB cells remained highly metabolically active when in contact with both dense and porous biocomposites.
In fact, their cell viability consistently exceeded the 70% threshold, indicating strong biocompatibility. It is worth noting that the porous biocomposites were made from PMMA, a structure porosity that, according to the literature [57], could potentially hinder biocompatibility and bioactivity. However, the results of this study are consistent with previous research investigating the in vitro cytotoxicity of biocomposites containing β-TCP and ZrO2 [1,45,58]. Also, as in other reported studies [57,58], the use of PMMA during manufacturing did not leave residues that could harm the cytotoxicity results.
As in previous studies [45], no relevant differences were detected in cell viability and proliferation between the pure TCP composition and the TCP compositions doped with combinations of the four metal ions, while the bioceramic composites of TCP with zirconia did not show high cell viability. This cell viability can be attributed to the range of molar concentrations of ions incorporated into the crystalline structure of β-TCP, which closely mimics the composition of natural human bone [14,45,59].
SEM was used to visualize cell attachment and growth on the PMMA-induced porous biocomposites. Figure 7 shows the results at 3000× and 5000× magnification after 3 days of incubation. In addition, SEM images of the biocomposites without hOB cells, magnified to 1200×, are included for comparison.
These images clearly show that hOB cells not only adhered to the surface but also infiltrated the interior of the biocomposites over time. This observation is consistent with previous research using β-TCP [60]. These results may be associated with the porosity present in the materials, whose macropores have an ideal average size between 100–200 μm for cell growth, and according to the literature [61,62,63] this directly influences cell proliferation, promoting cell adhesion and growth.

4. Conclusions

Ceramic biocomposites with different percentage of metal ion doped sTCP, 3YSZ, and 8YSZ, in dense form and with porosity induced by PMMA, were manufactured. The ceramic microstructure and the composition obtained have a good similarity with human bone biomimicry. The effect of doping with 15 mol% metal ions of Mg2+, Zn2+, Mn2+, and Fe3+ and simultaneously strengthening with two ZrO2 (tetragonal and cubic crystalline phases) was assessed through the physical, mechanical, microstructural, and biological properties.
XRD, EDX, and FTIR analyses show that metal ions are present in the composition and replace the calcium in the crystal structure of the biocomposites. The β-TCP crystalline phase is predominant; however, hydroxyapatite is also present in the reference material (sTCP), most likely due to mechanochemical synthesis during the mixing/grinding process. As expected, the tetragonal and cubic phases are also present in the biocomposites reinforced by the respective ZrO2. The images of the fracture surfaces show the porosity, interconnectivity, and fracture modes, while in the materials with induced porosity, voids generated by the PMMA spheres of approximately 100 microns are observed.
Moreover, from the analysis of the results, the following summary can be given:
(i)
The addition of 20 wt% of 3YSZ increases the mechanical strength to 16.4 MPa, 22% higher than sTCP; and 20 wt% of 8YSZ increases the strength to 20.7 MPa, 55% highest than reference doped sTCP. In this way, as expected, cubic zirconia promotes greater resistance than tetragonal zirconia.
(ii)
The apparent porosity increases 65%, from 12.6 to 24.6% with the addition of 10 wt% of 3YSZ and 60%, to 20.6% with the addition of 20 wt% of 8YSZ. This is justified by the sintering conditions of pressure-less, unassisted sintering, where the temperature is not sufficient to promote atomic migration along the zirconia grain boundary, promoting the formation of zirconia agglomerates and partial grain growing with poor densification.
(iii)
The use of PMMA increases the apparent porosity for all ceramic biocomposites; however, this effect is more visible for sTCP, where the value obtained of 26.2%, matches an increase of two times. In this case the mechanical resistance is too low for structural applications.
(iv)
The resazurin assay revealed that the two types of biocomposites produced did not affect the viability of hOB, presenting a cellular viability, in most cases, of 100%. These results highlight the ideal properties of these biocomposites as bone substitutes, especially the dense ones doped with 8YSZ, which showed a more constant behavior for the analyzed properties.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/biomimetics8080599/s1, Figure S1: X-ray diffraction spectra of the biocomposites 10T (sTCP) after calcination and after sintering and X-ray diffraction spectra of the theoretical cards #09-0432, #09-0169, and #09-0348, corresponding to HA, β-TCP and α-TCP, respectively; Figure S2: Apparent porosity of the composites: (a) dense reinforced with 3YSZ; (b) manufactured with PMMA and reinforced with 3YSZ; (c) dense reinforced with 8YSZ; (d) manufactured with PMMA and reinforced with 8YSZ; Figure S3: Bulk density of the composites: (a) dense reinforced with 3YSZ; (b) manufactured with PMMA and reinforced with 3YSZ; (c) dense reinforced with 8YSZ; (d) manufactured with PMMA and reinforced with 8YSZ; Figure S4: Mechanical strength of the composites: (a) dense reinforced with 3YSZ; (b) manufactured with PMMA and reinforced with 3YSZ; (c) dense reinforced with 8YSZ; (d) manufactured with PMMA and reinforced with 8YSZ.

Author Contributions

Conceptualization, A.P.S.; methodology, A.P.S., D.F.M. and N.F.F.; software, D.F.M.; formal analysis, V.M.F., D.F.M. and N.F.F.; investigation, V.M.F. and B.C.S.; resources, A.P.S.; writing—original draft preparation, V.M.F.; writing—review and editing, A.P.S., D.F.M. and N.F.F.; supervision, A.P.S.; project administration, A.P.S.; funding acquisition, A.P.S. All authors have read and agreed to the published version of the manuscript.

Funding

The research work was supported by FCT-Fundação para a Ciência e a Tecnologia, I.P./MCTES, through national funds (PIDDAC), within the scope of the Unit I&D: C-MAST, Projects UIDB/00151/2020 and UIDP/00151/2020; CICS-UBI, Projects UIDB/00709/2020 and UIDP/00709/2020.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The authors declare that the data supporting the findings of this study are available within the article.

Acknowledgments

The research work was supported by FCT-Fundação para a Ciência e a Tecnologia, I.P./MCTES, through national funds (PIDDAC), within the scope of the Unit I&D: C-MAST (Centre for Mechanical and Aerospace Science and Technology), Projects UIDB/00151/2020 and UIDP/00151/2020; CICS-UBI (Centro de Investigação em Ciências da Saúde), Projects UIDB/00709/2020 and UIDP/00709/2020. N.F.F. acknowledges his PhD fellowship from FCT (2022.14608.BD). D.F.M. also acknowledges his PhD fellowship from FCT (2022.14478.BD).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Vassal, M.F.; Nunes-Pereira, J.; Miguel, S.P.; Correia, I.J.; Silva, A.P. Microstructural, mechanical and biological properties of hydroxyapatite—CaZrO3 biocomposites. Ceram. Int. 2019, 45, 8195–8203. [Google Scholar] [CrossRef]
  2. Mantripragada, V.P.; Lecka-Czernik, B.; Ebraheim, N.A.; Jayasuriya, A.C. An overview of recent advances in designing orthopedic and craniofacial implants. J. Biomed. Mater. Res. 2013, 101, 3349–3364. [Google Scholar] [CrossRef] [PubMed]
  3. Dubok, V.A. Bioceramics—Yesterday, today, tomorrow. Powder Metall. Metal. Ceram. 2000, 39, 381–394. [Google Scholar] [CrossRef]
  4. Hisbergues, M.; Vendeville, S.; Vendeville, P. Review zirconia: Established facts and perspectives for a biomaterial in dental implantology. J. Biomed. Mater. Res. 2009, 88, 519–529. [Google Scholar] [CrossRef] [PubMed]
  5. Christel, P.; Meunier, A.; Heller, M.; Torre, J.P.; Peille, C.N. Mechanical properties and short-term in vivo evaluation of yttrium-oxide-partially-stabilized zirconia. J. Biomed. Mater. Res. 1989, 23, 45–61. [Google Scholar] [CrossRef]
  6. Nakonieczny, D.; Walke, W.; Majewska, J.; Paszenda, Z. Characterization of magnesia-doped yttria-stabilized zirconia powders for dental technology applications. Acta Bioeng. Biomech. 2014, 16, 97–104. [Google Scholar] [CrossRef]
  7. Boobalan, K.; Vijayaraghavan, R.; Chidambaram, K.; Mudali, U.M.K.; Raj, B. Preparation and characterization of nanocrystalline zirconia powders by the glowing combustion method. J. Am. Ceram. Soc. 2010, 93, 3651–3656. [Google Scholar] [CrossRef]
  8. Kelly, J.R.; Denry, I. Stabilized zirconia as a structural ceramic: An overview. Dent. Mater. 2008, 24, 289–298. [Google Scholar] [CrossRef]
  9. Nakonieczny, D.S.; Antonowicz, M.; Paszenda, Z.K.; Radko, T.; Drewniak, S.; Bogacz, W.; Krawcyk, C. Experimental investigation of particle size distribution and morphology of alumina-yttria-ceria-zirconia powders obtained via sol–gel route. Biocybern. Biomed. Eng. 2018, 38, 535–543. [Google Scholar] [CrossRef]
  10. Vasile, B.S.; Andronescu, E.; Ghitulica, C.; Vasile, O.R.; Curechiu, L.; Scurtu, R.; Vasile, E.; Trusca, R.; Pall, L.; Aldica, V. Microstructure and electrical properties of zirconia and composite nanostructured ceramics sintered by different methods. Ceram. Int. 2013, 39, 2535–2543. [Google Scholar] [CrossRef]
  11. Green, D.J.; Hannink, R.H.J.; Swain, M.V. Transformation Toughenung of Ceramics; CRC Press, Inc.: Boca Raton, FL, USA, 1989; Chapter 2; pp. 17–55. [Google Scholar]
  12. Chevalier, J.; Cales, B.; Drouin, J.M. Low-Temperature Aging of Y-TZP Ceramics. J. Am. Ceram. Soc. 2004, 82, 2150–2154. [Google Scholar] [CrossRef]
  13. Delfino, C.S.; Ribeiro, C.; Vieira, G.F.; Bressiani, A.H.A.; Turbino, M.L. The use of new materials for pulp capping (hydroxyapatite–HAp and tricalcium phosphate-β-TCP). Cerâmica 2010, 56, 381–388. [Google Scholar] [CrossRef]
  14. Macedo, D.F.; Silva, A.P. Analysis of the effect of doped metal ions in the tricalcium phosphate bioceramic. J. Phys. Conf. Ser. 2021, 1960, 012014. [Google Scholar] [CrossRef]
  15. Kwon, S.H.; Jun, Y.K.; Hong, S.H.; Kim, H.E. Synthesis and dissolution behavior of β-TCP and HA/β-TCP composite powders. J. Eur. Ceram. Soc. 2003, 23, 1039–1045. [Google Scholar] [CrossRef]
  16. Alcaide, M.; Serrano, M.C.; Pagani, R.; Sánchez-Salcedo, S.; Vallet-Regí, M.; Portolés, M.T. Biocompatibility markers for the study of interactions between osteoblasts and composite biomaterials. Biomaterials 2009, 30, 45–51. [Google Scholar] [CrossRef]
  17. Thamaraiselvi, T.V.; Rajeswari, S. Biological Evaluation of Bioceramic Materials-A Review. Trends Biomater. Artif. Organs 2004, 18, 9–17. [Google Scholar]
  18. Frasnelli, M.; Sglavo, V.M. Effect of Mg2+ doping on beta-alpha phase transition in tricalcium phosphate (TCP) bioceramics. Acta Biomater. 2016, 33, 283–289. [Google Scholar] [CrossRef]
  19. Yashima, M.; Sakai, A. High-temperature neutron powder diffraction study of the structural phase transition between α and α′ phases in tricalcium phosphate Ca3(PO4)2. Chem. Phys. Lett. 2003, 372, 779–783. [Google Scholar] [CrossRef]
  20. Ran, J.; Jiang, P.; Sun, G.; Ma, Z.; Hu, J.; Shen, X.; Tong, H. Comparisons among Mg, Zn, Sr, and Si doped nano-hydroxyapatite/chitosan composites for load-bearing bone tissue engineering applications. Mater. Chem. Front. 2017, 1, 900–910. [Google Scholar] [CrossRef]
  21. Baker, W.L. Treating arrhythmias with adjunctive magnesium: Identifying future research directions. Eur. Heart J. Cardiovasc. Pharmacother. 2017, 3, 108–117. [Google Scholar] [CrossRef]
  22. de Baaij, J.H.F.; Hoenderop, J.G.J.; Bindels, R.J.M. Magnesium in Man: Implications for Health and Disease. Physiol. Rev. 2015, 95, 1–46. [Google Scholar] [CrossRef] [PubMed]
  23. Zoroddu, M.A.; Aaseth, J.; Crisponi, G.; Medici, S.; Peana, M.; Nurchi, V.M. The essential metals for humans: A brief overview. J. Inorg. Biochem. 2019, 195, 120–129. [Google Scholar] [CrossRef] [PubMed]
  24. Enderle, R.; Götz-Neunhoeffer, F.; Göbbels, M.; Müller, F.A.; Greil, P. Influence of magnesium doping on the phase transformation temperature of β-TCP ceramics examined by Rietveld refinement. Biomaterials 2005, 26, 3379–3384. [Google Scholar] [CrossRef]
  25. Arcos, D.; Vallet-Regí, M. Substituted hydroxyapatite coatings of bone implants. J. Mater. Chem. B 2020, 8, 1781–1800. [Google Scholar] [CrossRef] [PubMed]
  26. Banerjee, S.S.; Tarafder, S.; Davies, N.M.; Bandyopadhyay, A.; Bose, S. Understanding the influence of MgO and SrO binary doping on the mechanical and biological properties of β-TCP ceramics. Acta Biomater. 2010, 6, 4167–4174. [Google Scholar] [CrossRef]
  27. Bose, S.; Tarafder, S.; Banerjee, S.S.; Davies, N.M.; Bandyopadhyay, A. Understanding in vivo response and mechanical property variation in MgO, SrO and SiO2 doped β-TCP. Bone 2011, 48, 1282–1290. [Google Scholar] [CrossRef]
  28. Singh, R.K.; Srivastava, M.; Prasad, N.K.; Awasthi, S.; Dhayalan, A.; Kannan, S. Iron doped β-Tricalcium phosphate: Synthesis, characterization, hyperthermia effect, biocompatibility and mechanical evaluation. Mater. Sci. Eng. C 2017, 78, 715–726. [Google Scholar] [CrossRef]
  29. Tarafder, S.; Davies, N.M.; Bandyopadhyay, A.; Bose, S. 3D printed tricalcium phosphate bone tissue engineering scaffolds: Effect of SrO and MgO doping on in vivo osteogenesis in a rat distal femoral defect model. Biomater. Sci. 2013, 1, 1250–1259. [Google Scholar] [CrossRef]
  30. Rodríguez, J.; Mandalunis, P.M. A review of metal exposure and its effects on bone health. J. Toxicol. 2018, 2018, 4854152. [Google Scholar] [CrossRef]
  31. Lee, Y.H.; Lee, J.W.; Yang, S.Y.; Lee, H.; Koh, Y.H.; Kim, H.E. Dual-scale porous biphasic calcium phosphate gyroid scaffolds using ceramic suspensions containing polymer microsphere porogen for digital light processing. Ceram. Int. 2021, 47, 11285–11293. [Google Scholar] [CrossRef]
  32. Sa, Y.; Yang, F.; De Wijn, J.R.; Wang, Y.; Wolke, J.G.C.; Jansen, J.A. Physicochemical properties and mineralization assessment of porous polymethylmethacrylate cement loaded with hydroxyapatite in simulated body fluid. Mater. Sci. Eng. C 2016, 61, 190–198. [Google Scholar] [CrossRef]
  33. Shi, M.; Kretlow, J.D.; Nguyen, A.; Young, S.; Baggett, L.S.; Wong, M.E.; Kasper, F.K.; Mikos, A.G. Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control. Biomaterials 2010, 31, 4146–4156. [Google Scholar] [CrossRef]
  34. Descamps, M.; Duhoo, T.; Monchau, F.; Lu, J.; Hardouin, P.; Hornez, J.C.; Leriche, A. Manufacture of macroporous β-tricalcium phosphate bioceramics. J. Eur. Ceram. Soc. 2008, 28, 149–157. [Google Scholar] [CrossRef]
  35. Nunes-Pereira, J.; Carneiro, P.M.C.; Maceiras, A.; Baudín, C.; Silva, A.P. Modelling of elastic modulus of CaZrO3-MgO composites using isotropic elastic and anisotropic models. J. Eur. Ceram. Soc. 2020, 40, 5882–5890. [Google Scholar] [CrossRef]
  36. Rodriguez-Carvajal, J. Recent developments of the program FULLPROF, commission on powder diffraction. Comm. Powder Diffr. (IUCr) 2001, 26, 12–19. [Google Scholar]
  37. ASTM C179-04; ASTM Standard Test Method for Drying and Firing Linear Change of Refractory Plastic and Ramming Mix Specimens. ASTM: West Conshohocken, PA, USA, 2004; pp. 1–2. Available online: www.astm.org (accessed on 2 May 2023).
  38. Jonsén, P.; Häggblad, H.Å.; Sommer, K. Tensile strength and fracture energy of pressed metal powder by diametral compression test. Powder Technol. 2007, 176, 148–155. [Google Scholar] [CrossRef]
  39. García-Páez, I.H.; Carrodeguas, R.G.; De Aza, A.H.; Baudín, C.; Pena, P. Effect of Mg and Si co-substitution on microstructure and strength of tricalcium phosphate ceramics. J. Mech. Behav. Biomed. Mater. 2014, 30, 1–15. [Google Scholar] [CrossRef] [PubMed]
  40. O’Brien, J.; Wilson, I.; Orton, T.; Pognan, F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 2000, 267, 5421–5426. [Google Scholar] [CrossRef]
  41. Sequeira, R.S.; Miguel, S.P.; Cabral, C.S.D.; Moreira, A.F.; Ferreira, P.; Correia, I.J. Development of a poly(vinyl alcohol)/lysine electrospun membrane-based drug delivery system for improved skin regeneration. Int. J. Pharm. 2019, 570, 118640. [Google Scholar] [CrossRef]
  42. Fernandes, N.; Rodrigues, C.F.; de Melo-Diogo, D.; Correia, I.J.; Moreira, A.F. Optimization of the gsh-mediated formation of mesoporous silica-coated gold nanoclusters for nir light-triggered photothermal applications. Nanomaterials 2021, 11, 1946. [Google Scholar] [CrossRef] [PubMed]
  43. Yeong, B.; Junmin, X.; Wang, J. Mechanochemical synthesis of hydroxyapatite from calcium oxide and brushite. J. Am. Ceram. Soc. 2001, 84, 465–467. [Google Scholar] [CrossRef]
  44. Toriyama, M.; Ravaglioli, A.; Krajewski, A.; Celotti, G.; Piancastelli, A. Synthesis of Hydroxyapatite-Based Powders by Mechano-Chemical Method and their Sintering. J. Eur. Ceram. Soc. 1996, 16, 429–436. [Google Scholar] [CrossRef]
  45. Macedo, D.F.; Cunha, A.F.; Mano, J.F.; Oliveira, M.B.; Silva, A.P. Tricalcium phosphate doped with Mg2+ and combinations of Mn2+, Zn2+ and Fe3+: A DoE study on sintering, mechanical, microstructural and biological properties. Ceram. Int. 2022, 48, 20467–20477. [Google Scholar] [CrossRef]
  46. Wu, S.; Liu, X.; Yeung, K.W.K.; Liu, C.; Yang, X. Biomimetic porous scaffolds for bone tissue engineering. Mater. Sci. Eng. R Rep. 2014, 80, 1–36. [Google Scholar] [CrossRef]
  47. Xidaki, D.; Agrafioti, P.; Diomatari, D.; Kaminari, A.; Tsalavoutas-Psarras, E.; Alexiou, P.; Psycharis, V.; Tsilibary, E.C.; Silvestros, S.; Sagnou, M. Synthesis of hydroxyapatite, β-Tricalcium phosphate and biphasic calcium phosphate particles to act as local delivery carriers of curcumin: Loading, release and in vitro studies. Materials 2018, 11, 595. [Google Scholar] [CrossRef] [PubMed]
  48. Nahar, U.K.; Shovon, B.; Chandra, D.R.; Chandra, P.S.; Shukanta, B.; Muhammed, Y.M.; Islam, M.D.S. Characterization of Beta-Tricalcium Phosphate (β- TCP) Produced at Different Process Conditions. J. Bioeng. Biomed. Sci. 2017, 7, 2. [Google Scholar] [CrossRef]
  49. Dwivedi, R.; Maurya, A.; Verma, A.; Prasad, R.; Bartwal, K.S. Microwave assisted sol-gel synthesis of tetragonal zirconia nanoparticles. J. Alloys Compd. 2011, 509, 6848–6851. [Google Scholar] [CrossRef]
  50. Manjunatha, S.; Dharmaprakash, M.S. Microwave assisted synthesis of cubic Zirconia nanoparticles and study of optical and photoluminescence properties. J. Lumin. 2016, 180, 20–24. [Google Scholar] [CrossRef]
  51. Hotza, D.; García, D.E.; Castro, R.H.R. Obtaining highly dense YSZ nanoceramics by pressureless, unassisted sintering. Int. Mater. Rev. 2015, 60, 353–375. [Google Scholar] [CrossRef]
  52. Booth, F.; Garrido, L.; Aglietti, E.; Silva, A.; Pena, P.; Baudín, C. CaZrO3-MgO structural ceramics obtained by reaction sintering of dolomite-zirconia mixtures. J. Eur. Ceram. Soc. 2016, 36, 2611–2626. [Google Scholar] [CrossRef]
  53. Silva, A.P.; Booth, F.; Garrido, L.; Aglietti, E.; Pena, P.; Baudín, C. Young’s modulus and hardness of multiphase CaZrO3-MgO ceramics by micro and nanoindentation. J. Eur. Ceram. Soc. 2018, 38, 2194–2201. [Google Scholar] [CrossRef]
  54. Ayoub, G.; Veljovic, D.; Zebic, M.L.; Miletic, V.; Palcevskis, E.; Petrovic, R.; Janackovic, D. Composite nanostructured hydroxyapatite/yttrium stabilized zirconia dental inserts—The processing and application as dentin substitutes. Ceram. Int. 2018, 44, 18200–18208. [Google Scholar] [CrossRef]
  55. Castkova, K.; Hadraba, H.; Matousek, A.; Roupcova, P.; Chlup, Z.; Novotna, L.; Cihlar, J. Synthesis of Ca,Y-zirconia/hydroxyapatite nanoparticles and composites. J. Eur. Ceram. Soc. 2016, 36, 2903–2912. [Google Scholar] [CrossRef]
  56. Albrektsson, T.; Johansson, C. Osteoinduction, osteoconduction and osseointegration. Eur. Spine J. 2001, 10, S96–S101. [Google Scholar] [CrossRef]
  57. Sugino, A.; Miyazaki, T.; Kawachi, G.; Kikuta, K.; Ohtsuki, C. Relationship between apatite-forming ability and mechanical properties of bioactive PMMA-based bone cement modified with calcium salts and alkoxysilane. J. Mater. Sci. Mater. Med. 2008, 19, 1399–1405. [Google Scholar] [CrossRef]
  58. Jäger, M.; Wilke, A. Comprehensive biocompatibility testing of a new PMMA-HA bone cement versus conventional PMMA cement in vitro. J. Biomater. Sci. Polym. Ed. 2003, 14, 1283–1298. [Google Scholar] [CrossRef] [PubMed]
  59. Hurle, K.; Oliveira, J.M.; Reis, R.L.; Pina, S.; Goetz-Neunhoeffer, F. Ion-doped Brushite Cements for Bone Regeneration. Acta Biomater. 2021, 123, 51–71. [Google Scholar] [CrossRef]
  60. Lu, J.X.; Flautre, B.; Anselme, K.; Hardouin, P.; Gallur, A.; Descamps, M.; Thierry, B. Role of interconnections in porous bioceramics on bone recolonization in vitro and in vivo. J. Mater. Sci. Mater. Med. 1999, 10, 111–120. [Google Scholar] [CrossRef]
  61. Volkmer, T.M.; Santos, L.A.D. Influence of the induction time on the properties of porous hydroxyapatite obtained by gelcasting foams. Cerâmica 2007, 53, 429–435. [Google Scholar] [CrossRef]
  62. Flautre, B.; Descamps, M.; Delecourt, C.; Blary, M.C.; Hardouin, P. Porous HA ceramic for bone replacement: Role of the pores and interconnections—Experimental study in the rabbit. J. Mater. Sci. Mater. Med. 2001, 12, 679–682. [Google Scholar] [CrossRef]
  63. Klawitter, J.J.; Bagwell, J.G.; Weinstein, A.M.; Sauer, B.W. An Evaluation of Bone Growth into Porous High Density Polyethylene. J. Biomed. Mater. Res. 1976, 10, 311–323. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Particle size distribution of powders of the mixtures 10T (sTCP), 8T2cZ, and 8T2tZ: (A) differential volume; (B) cumulative number.
Figure 1. Particle size distribution of powders of the mixtures 10T (sTCP), 8T2cZ, and 8T2tZ: (A) differential volume; (B) cumulative number.
Biomimetics 08 00599 g001
Figure 2. Illustration of a valid diametral compression test: (a) 10T and (b) 8T2tZ dense samples; (c) 10T, and (d) 8T2tZ porous samples.
Figure 2. Illustration of a valid diametral compression test: (a) 10T and (b) 8T2tZ dense samples; (c) 10T, and (d) 8T2tZ porous samples.
Biomimetics 08 00599 g002
Figure 3. SEM characteristic fracture surfaces of the ceramic biocomposites. Dense biocomposites with a magnification of 1000× and 5000× and porous biocomposites with a magnification of 100× and 200×. Examples of transgranular and intergranular fracture surfaces are illustrated by letters “T” and “I”, respectively.
Figure 3. SEM characteristic fracture surfaces of the ceramic biocomposites. Dense biocomposites with a magnification of 1000× and 5000× and porous biocomposites with a magnification of 100× and 200×. Examples of transgranular and intergranular fracture surfaces are illustrated by letters “T” and “I”, respectively.
Biomimetics 08 00599 g003
Figure 4. X-ray diffraction spectra of the biocomposites 10T, 8T2tZ, and 8T2cZ and X-ray diffraction spectra of the theoretical cards #37-1484, #50-1089, #49-1642, #09-0432, #09-0169, and #09-0348, corresponding to m-ZrO2, t-ZrO2 (♣), c-ZrO2 (♦), HA (♠), β-TCP (♥), and α-TCP, respectively.
Figure 4. X-ray diffraction spectra of the biocomposites 10T, 8T2tZ, and 8T2cZ and X-ray diffraction spectra of the theoretical cards #37-1484, #50-1089, #49-1642, #09-0432, #09-0169, and #09-0348, corresponding to m-ZrO2, t-ZrO2 (♣), c-ZrO2 (♦), HA (♠), β-TCP (♥), and α-TCP, respectively.
Biomimetics 08 00599 g004
Figure 5. FTIR spectra of different biocomposites 10T, 8T2tZ, and 8T2cZ.
Figure 5. FTIR spectra of different biocomposites 10T, 8T2tZ, and 8T2cZ.
Biomimetics 08 00599 g005
Figure 6. Evaluation of the cytocompatibility of biocomposites: (A) dense samples reinforced with 3YSZ and 8YSZ; (B) porous samples reinforced with 3YSZ and 8YSZ.
Figure 6. Evaluation of the cytocompatibility of biocomposites: (A) dense samples reinforced with 3YSZ and 8YSZ; (B) porous samples reinforced with 3YSZ and 8YSZ.
Biomimetics 08 00599 g006
Figure 7. SEM images of cellular attachment to porous biocomposites after 3 days and without cellular attachment, with magnifications of 3000×, 5000× and 1200×, respectively.
Figure 7. SEM images of cellular attachment to porous biocomposites after 3 days and without cellular attachment, with magnifications of 3000×, 5000× and 1200×, respectively.
Biomimetics 08 00599 g007
Table 1. Nomenclature and composition of the materials studied in molar fraction (xi), volumetric fraction (vi) and mass fraction (wi).
Table 1. Nomenclature and composition of the materials studied in molar fraction (xi), volumetric fraction (vi) and mass fraction (wi).
MaterialsMolar Fraction
xi
Volumetric Fraction
vi
Mass Fraction
wi
sTCP3YSZ8YSZsTCP3YSZ8YSZsTCP3YSZ8YSZ
10T100100100
9T1tZ0.78140.218600.94730.052700.90.10
8T2tZ0.61380.386200.88880.111200.80.20
9T1cZ0.781400.21860.946800.05320.900.1
8T2cZ0.613800.38620.887700.11230.800.2
Table 2. Quantitative analysis (%vol) of XRD for bioceramic composites 10T, 8T2tZ, and 8T2cZ, by Rietveld refinement.
Table 2. Quantitative analysis (%vol) of XRD for bioceramic composites 10T, 8T2tZ, and 8T2cZ, by Rietveld refinement.
Phases (%vol)10T8T2tZ8T2cZ
β-TCP77.60 ± 0.0071.09 ± 1.0077.50 ± 0.00
HA21.9 ± 0.003.05 ± 0.02-
α-TCP0.72 ± 0.00--
t-ZrO2-25.86 ± 0.541.48 ± 0.00
c-ZrO2--21.02 ± 0.00
Table 3. Chemistry analysis (EDX) of the ceramic biocomposites 10T, 8T2tZ, and 8T2cZ. The error is the standard deviation (sd).
Table 3. Chemistry analysis (EDX) of the ceramic biocomposites 10T, 8T2tZ, and 8T2cZ. The error is the standard deviation (sd).
Element10T8T2tZ8T2cZ
wt%mol%sd wt%wt%mol%sd wt%wt%mol%sd wt%
Ca46.730.022.236.824.612.0137.9328.652.03
P17.4314.51.1210.429.020.7911.2410.950.84
O33.5153.979.0936.3360.879.7627.5952.047.85
Mg0.780.820.150.650.720.140.620.780.13
Mn0.470.220.110.350.170.090.250.140.09
Fe0.480.220.110.140.070.080.310.170.09
Zn0.640.250.130.370.150.110.550.250.12
Zr---14.954.391.121.57.111.52
Table 4. Diametral compression for dense and porous bioceramic composites.
Table 4. Diametral compression for dense and porous bioceramic composites.
sTCPsTCP + t-ZrO2sTCP + c-ZrO2
10T9T1tZ8T2tZ9T1cZ8T2cZ
Dense biocomposites
13.36 ± 1.612.85 ± 1.616.40 ± 1.415.22 ± 1.520.74 ± 1.6
Porous biocomposites
1.28 ± 0.30.16 ± 0.10.10 ± 0.00.20 ± 0.00.14 ± 0.1
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ferro, V.M.; Silva, B.C.; Macedo, D.F.; Fernandes, N.F.; Silva, A.P. TCP Doped with Metal Ions Reinforced with Tetragonal and Cubic Zirconia. Biomimetics 2023, 8, 599. https://doi.org/10.3390/biomimetics8080599

AMA Style

Ferro VM, Silva BC, Macedo DF, Fernandes NF, Silva AP. TCP Doped with Metal Ions Reinforced with Tetragonal and Cubic Zirconia. Biomimetics. 2023; 8(8):599. https://doi.org/10.3390/biomimetics8080599

Chicago/Turabian Style

Ferro, Vanessa M., Beatriz C. Silva, Duarte F. Macedo, Natanael F. Fernandes, and Abílio P. Silva. 2023. "TCP Doped with Metal Ions Reinforced with Tetragonal and Cubic Zirconia" Biomimetics 8, no. 8: 599. https://doi.org/10.3390/biomimetics8080599

Article Metrics

Back to TopTop